Bibliographic Details
Title: |
Efficacy of a Mobile Health–Based Behavioral Treatment for Lifestyle Modification in Type 2 Diabetes Self-Management: Greenhabit Randomized Controlled Trial |
Authors: |
Ana Maria Ruiz-Leon, Rosa Casas, Sara Castro-Barquero, Sofia Alfaro-González, Petia Radeva, Emilio Sacanella, Francesc Casanovas-Garriga, Ainhoa Pérez-Gesalí, Ramon Estruch |
Source: |
Journal of Medical Internet Research, Vol 27, p e58319 (2025) |
Publisher Information: |
JMIR Publications, 2025. |
Publication Year: |
2025 |
Collection: |
LCC:Computer applications to medicine. Medical informatics LCC:Public aspects of medicine |
Subject Terms: |
Computer applications to medicine. Medical informatics, R858-859.7, Public aspects of medicine, RA1-1270 |
More Details: |
BackgroundEnhancing self-management in health care through digital tools is a promising strategy to empower patients with type 2 diabetes (T2D) to improve self-care. ObjectiveThis study evaluates whether the Greenhabit (mobile health [mHealth]) behavioral treatment enhances T2D outcomes compared with standard care. MethodsA 12-week, parallel, single-blind randomized controlled trial was conducted with 123 participants (62/123, 50%, female; mean age 58.25 years, SD 9.46 years) recently diagnosed with T2D. Participants were recruited face-to-face from primary care centers in Barcelona, Spain, between July 2021 and March 2022. They were randomly assigned to 1 of 2 groups: (1) an intervention group (n=61) instructed to use the Greenhabit mobile app alongside standard care, or (2) a control group (n=62) who received advice on maintaining a healthy diet and followed standard care. The Greenhabit app incorporates serious gaming technology. Participants received daily messages and challenges focused on promoting a healthy lifestyle, including nutrition, exercise, relaxation, a positive mindset, and a supportive social environment. The app encouraged participants to set weekly goals and awarded points for completing challenges. Data on nutrition, anthropometrics, and blood and urine samples were collected at baseline, 6 weeks, and 12 weeks. Questionnaires assessing quality of life, work-life balance, and social environment were administered at baseline and during the final visit. The primary outcomes were HbA1c and fasting plasma glucose (FPG). Repeated-measures analysis of variance was used to compare changes over time (baseline to 6 weeks and baseline to 12 weeks) between the 2 intervention groups. Analysis of covariance was performed to evaluate changes at 6 and 12 weeks, adjusted for baseline levels of each variable. Multiple contrasts were corrected using a Bonferroni post hoc test. ResultsBoth groups showed significant reductions in HbA1c after 6 and 12 weeks (mean change in the intervention group [n=50] –0.4%, P |
Document Type: |
article |
File Description: |
electronic resource |
Language: |
English |
ISSN: |
1438-8871 |
Relation: |
https://www.jmir.org/2025/1/e58319; https://doaj.org/toc/1438-8871 |
DOI: |
10.2196/58319 |
Access URL: |
https://doaj.org/article/3435801298a5409ba59df9b93b5dacc9 |
Accession Number: |
edsdoj.3435801298a5409ba59df9b93b5dacc9 |
Database: |
Directory of Open Access Journals |